Try our Advanced Search for more refined results

In Re: Loestrin 24 FE

  1. February 23, 2016

    Loestrin Ruling Signals Non-Cash Deals Won't Evade Actavis

    With its ruling Monday that Warner Chilcott's noncash settlements with generics makers over its contraceptive Loestrin could face antitrust scrutiny, the First Circuit fell into line with other courts and brought some possible closure to the debate over whether a "payment" under the U.S. Supreme Court's Actavis decision must be cash, attorneys say.

  2. February 22, 2016

    1st Circ. Revives Loestrin Pay-For-Delay Suit

    Warner Chilcott will have to face claims it paid drugmakers to delay producing a generic version of its contraceptive Loestrin in multidistrict litigation after the First Circuit on Monday found that noncash settlements can be subject to antitrust scrutiny.

  3. November 16, 2015

    Loestrin Pay-For-Delay Suit Lacks Hard Data, 1st Circ. Told

    Warner Chilcott told the First Circuit on Friday that wholesalers, end payors and others alleging a pay-for-delay scheme involving its contraceptive Loestrin in multidistrict litigation have to demonstrate the value of noncash settlements at the heart of the case in order to support their reverse-payment claims.

  4. September 25, 2015

    1st Circ. Told Warner Chilcott Paid Actavis To Kill Competition

    Plaintiffs trying to get their pay-for-delay suit over Loestrin revived urged the First Circuit Thursday to reverse the district court ruling dismissing the case, saying Warner Chilcott PLC made millions of dollars off of a weak patent for the contraceptive and then paid off Actavis to stay out of the market.

  5. August 28, 2015

    Lupin, Allergan Get Support In Pay-For-Delay Fight At 1st Circ.

    Manufacturers and generic drug companies have rallied behind Lupin Pharmaceuticals Inc. and Allergan PLC in pay-for-delay litigation at the First Circuit, telling the court Thursday that Loestrin buyers' sweeping definition of "reverse payments" doesn't fit with a recent U.S. Supreme Court decision.

  6. August 21, 2015

    Drug Cos. Say Loestrin Buyers Trying To Expand Actavis

    Lupin Pharmaceuticals Inc. and Allergan PLC told the First Circuit Friday that Loestrin buyers were trying to turn the U.S. Supreme Court's ruling allowing pay-for-delay deals to face antitrust scrutiny into a "blank check" that would even target settlements without large and unjustified payments.

  7. July 08, 2015

    Antitrust Cases To Watch In The 2nd Half Of 2015

    The first half of 2015 was action-packed with rulings on key pharmaceutical antitrust issues and agency wins in high-profile challenges, but there's still plenty to watch for over the next six months, including cases that could alter the landscape of college sports and professional baseball and major challenges to benchmark banking rates.

  8. June 17, 2015

    FTC Pushes 1st Circ. To Revive Loestrin Pay-For-Delay Suit

    The Federal Trade Commission warned the First Circuit Tuesday not to "illogically" put form over substance when it decides whether reverse payments must be cash in an appeal to revive an antitrust class action over oral contraceptive Loestrin.

  9. June 16, 2015

    AAI, Profs Push 1st Circ. To Overturn Pay-For-Delay Ruling

    The American Antitrust Institute and 70 law professors urged the First Circuit on Tuesday to rule that pharmaceutical patent settlements need not include cash to qualify as pay-for-delay deals under federal antitrust law in an appeal over oral contraceptive Loestrin.

  10. June 10, 2015

    1st Circ. Told Not To Focus On Cash In Loestrin Pay-For-Delay

    American Sales Co. LLC, Rochester Drug Co-Operative Inc. and end-payor plaintiffs in pay-for-delay litigation against Warner Chilcott PL over Loestrin urged the First Circuit Tuesday to overturn a lower court's decision that patent settlements must include cash payments to face antitrust scrutiny, saying fixating on cash ignores economic realities.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!